Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

Core Viewpoint - Mind Medicine (MindMed) Inc. has successfully closed its underwritten public offering of 21,131,250 common shares, which includes the full exercise of the underwriters' option to purchase an additional 2,756,250 common shares at a public offering price [1] Group 1 - The company is a late-stage clinical biopharmaceutical firm focused on developing novel product candidates aimed at treating brain health disorders [1] - The total number of common shares offered in the public offering was 21,131,250, which includes an additional 2,756,250 shares purchased by underwriters [1]